Funding for this research was provided by:
Frank H Netter MD School of Medicine Summer Research Fellowship
Article History
Received: 28 February 2021
Accepted: 3 November 2021
First Online: 17 November 2021
Declarations
:
: Because our examination of trial publications did not involve human subjects, ethics committee review was not required by the Yale University Human Research Protection Program. Consent to participate is not applicable.
: Not applicable.
: JLJ has received support from the FDA through the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program. JSR currently receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing; from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST); from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938); from the Agency for Healthcare Research and Quality (R01HS022882); from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164, R01HL144644); and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International. MJS declares that he has no competing interests.